logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-105. All clients entering inpatient treatment by primary drug and age, 2010 or most recent year available

Part (vi) All volatile inhalant inpatient clients by country and age

Country<1515-1920-2425-2930-3435-3940-4445+Age knownAge not knownTotal
Belgium111000000202
Bulgaria00010211505
Czech Republic21312000909
Denmark00000000000
Germany0132311213013
Estonia:::::::::::
Ireland01000000101
Greece00000000000
Spain:::::::::::
France:::::::::::
Italy:::::::::::
Cyprus00000000000
Latvia:::::::::::
Lithuania:::::::::::
Luxembourg:::::::::::
Hungary00000000000
Malta:::::::::::
Netherlands00100010202
Austria00100000101
Poland21420210010010
Portugal:::::::::::
Romania1956000122022
Slovenia:::::::::::
Slovakia41196261241041
Finland00000000000
Sweden00100011303
Uk300102000303
Croatia00211100505
Turkey81164734219412401241
Norway00100001202
Total1714476513320993591360
 

Notes:

: Indicates no data are available.

(1) In Belgium if the exact primary drug is not known, the generic category is recorded. In 2010 there were 96 Opiates, 1 Cocaine and 1 Hypnotics and Sedatives clients with the primary exact drug unknown. Of which 3 and 1 were new clients for respectively Opiates and Cocaine.

(2) Data are from 2009. Data presented in the table come from TDI pilot project. Caution should be made when interpreting the data

(3) Data are from 1st of April 2009 to 31st March 2010.

See also 'tdi-10-p12345678-07-Age distribution summary.xls' 'partvii',' partviii' and 'General notes for interpreting data' on the Explanatory notes and help page.

Source:

2011 REITOX National Reports - Table TDI Inpatient Treatment Centres

Page last updated: Monday, 09 July 2012